May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Effect of Selective Laser Trabeculoplasty (SLT) in Open Angle Glaucoma Patients With Previous 360 Degree Argon Laser Trabeculoplasty (ALT) Treatment
Author Affiliations & Notes
  • J.T. Mucciolo
    Eye Research Foundation and East Florida Eye Insti, Stuart, FL, United States
  • R.E. Frenkel
    Bascom Palmer Eye Institute, University of Miami; Eye Research Foundation, East Florida Eye Insti, Stuart, FL, United States
  • Footnotes
    Commercial Relationships  J.T. Mucciolo, None; R.E.P. Frenkel, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2202. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.T. Mucciolo, R.E. Frenkel; The Effect of Selective Laser Trabeculoplasty (SLT) in Open Angle Glaucoma Patients With Previous 360 Degree Argon Laser Trabeculoplasty (ALT) Treatment . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2202.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine if using SLT is beneficial for advanced glaucoma patients with uncontrolled IOP when used as retreatment in patients whom have had prior 360 degree ALT and who are on maximum tolerated medical therapy (MTMT). Methods: In a prospective, consecutive study, 77 eyes of 64 patients with advanced open angle glaucoma who had uncontrolled IOP on MTMT and who had prior 360 degree ALT treatment received treatment with SLT. Baseline IOP was taken as the mean of the two visits immediately preceeding the laser treatment. Patients’ eyes were treated with 50 spots over 180 degrees of the angle with .7-.8 millijoules using the Lumenis Selecta II laser. Acular was given q.i.d. postoperatively for 1 day. IOP was measured at 3-4 months post laser and compared to baseline. 3 patients were dropped from the study due a change in their glaucoma medication. All other patients had no change in their glaucoma medications during the study. Results: Mean baseline IOP was 16.67 mmHg. At 3-4 months post-laser the mean IOP was 16.54 mmHg (p>.9). There was no statistically significant IOP lowering in this group of patients. Conclusions: SLT is not effective at 3-4 months for retreatment after ALT in advanced glaucoma patients on MTMT.

Keywords: laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×